From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine

Equity Insider News Commentary

Issued on behalf of Avant Technologies Inc.

VANCOUVER, BC, July 16, 2025 /CNW/ -- Equity Insider News Commentary – Increased usage of AI in healthcare is predicted to not only save lives, but money too. However, the rollout of this industry-changing tech isn't going to happen overnight. The use of AI in healthcare is being pushed by the World Economic Forum (WEF) to provide in its words, a "healthier, more equitable world." A recent study published in Nature introduced a new "AI Affinity Score" designed to measure how comfortable patients are with artificial intelligence in their healthcare journey. The researchers found that factors like education and geographic region play a major role in shaping patient attitudes—and that the score could be used to tailor AI-driven tools in a way that improves both outcomes and satisfaction. With the global AI healthcare market projected to exceed $110 billion by 2030, companies such as Avant Technologies, Inc. (OTC-BB:AVAI), Tevogen Bio Holdings Inc. (NASDAQ:TVGN), Microsoft Corporation (NASDAQ:MSFT), Personalis, Inc. (NASDAQ:PSNL), and Tempus AI, Inc. (NASDAQ:TEM).